Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-02-18 / J Immunother Cancer 2014;2:4Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-02-05 / Cancer Immunol Res 2014 May;2(5):404-9Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2014-01-13 / Hum Vaccin Immunother 2014;10(4):970-6Concomitant gemcitabine therapy negatively affects DC vaccine-induced CD8(+) T-cell and B-cell responses but improves clinical efficacy in a murine pancreatic carcinoma model
/in Dendritic Cells, International Publications /von 2014-01-03 / Cancer Immunol. Immunother. 2014 Apr;63(4):321-33Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of function
/in Colorectal Cancer, Dendritic Cells, International Publications, IOZK Veröffentlichungen /von 2014-01-01 / Expert Rev Vaccines 2014 Jan;13(1):117-30Dendritic cell-based vaccines: clinical applications in breast cancer
/in Breast Cancer, Dendritic Cells, International Publications /von 2014-01-01 / Immunotherapy 2014;6(3):349-60Antigen trapping by dendritic cells for antitumor therapy
/in Dendritic Cells, International Publications /von 2014-01-01 / Methods Mol. Biol. 2014;1139:33-40Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies
/in Acute Leukemia, Dendritic Cells, International Publications, Multiple Myeloma /von 2014-01-01 / Hum Vaccin Immunother 2014;10(11):3125-31Generation of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccine
/in Dendritic Cells, International Publications /von 2014-01-01 / Methods Mol. Biol. 2014;1139:17-26IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de